A25 | Early antiretroviral therapy favors post-treatment SIV control, which is associated with enhanced CD8+ T-cell antiviral activity against rebounding virus ' the pVISCONTI study | On-demand oral abstract session | HIV-1 controllers (including post-treatment controllers) and long-term non-progressors |
A19 | Evaluation of HIV-1 reservoir size and broadly neutralizing antibody (bNAb) susceptibility in individuals who initiated ART during acute and chronic infection | On-demand oral abstract session | Characterizing HIV/SIV reservoirs and rebounding virus |
B80 | Robust SARS-CoV-2-specific serological and functional t-cell immunity in PLWHIV | On-demand oral abstract session | Immune responses against SARS-CoV2 in PLWHIV |
B30 | Rising substance use linked to STI and HCV in Thai MSM after acute HIV infection | On-demand oral abstract session | Substance abuse (including opioid use disorder) |
B13 | High HCV cure rates in C-FREE, first community-based study offering testing and treatment of viral hepatitis and HIV among people who use drugs and their partners in Thailand | On-demand oral abstract session | Viral hepatitis C |
B13 | Reaching HCV micro-elimination in HIV/HCV co-infected individuals in the Netherlands: exploring remaining barriers to HCV treatment | On-demand oral abstract session | Viral hepatitis C |
B13 | Evaluation of the HCV cascade of care among people with HIV/hepatitis C co-infection in New South Wales, Australia: a data linkage study | On-demand oral abstract session | Viral hepatitis C |
B11 | Outcomes and incidence of TB among people living with HIV who received TB preventive therapy in Uganda | On-demand oral abstract session | Tuberculosis and other mycobacteria |
B3 | The clinical effects of durably low CD4 counts while virologically suppressed among ART-initiating persons with HIV in Latin America | On-demand oral abstract session | Determinants of HIV progression and disease control |
B11 | Correlates associated with mortality among HIV-TB co-infected patients in Mumbai, India | On-demand oral abstract session | Tuberculosis and other mycobacteria |